Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review
Sign Up to like & getrecommendations! Published in 2021 at "Drugs"
DOI: 10.1007/s40265-021-01587-x
Abstract: The number of patients on long-term anti-osteoporotic drug therapy is rising. Unfortunately, there are few data to guide decisions about duration of pharmacologic therapy for osteoporosis. Many practitioners discontinue therapy after a period of 5… read more here.
Keywords: risk; discontinuation therapy; bone mineral; anti osteoporotic ... See more keywords
Discontinuation of Therapy in Hypertension Research: Value, Ethics, Risk, and Role in Renal Denervation Trials.
Sign Up to like & getrecommendations! Published in 2017 at "Hypertension"
DOI: 10.1161/hypertensionaha.117.08884
Abstract: See related article, pp 927–932 Less than 60 years ago, 2 studies were published that when read together constitute a surrogate for the first clinical trial in hypertension research. In the first, Priscilla Kincaid-Smith et… read more here.
Keywords: discontinuation therapy; blood pressure; hypertension research; hypertension ... See more keywords